title: [Transplacental passage of the pyrimethamine-sulfadoxine combination in the prenatal treatment of congenital toxoplasmosis].
authors: P
authors: P
authors: Dorangeon
authors: R
authors: R
authors: Fay
authors: C
authors: C
authors: Marx-Chemla
authors: B
authors: B
authors: Leroux
authors: G
authors: G
authors: Harika
authors: D
authors: D
authors: Dupouy
authors: C
authors: C
authors: Quereux
authors: H
authors: H
authors: Choisy
authors: J M
authors: JM
authors: Pinon
authors: P
authors: P
authors: Wahl
mesh_terms: D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange / Q000187:drug effects*; D011247:Pregnancy; D011739:Pyrimethamine / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*; D013413:Sulfadoxine / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*; D014125:Toxoplasmosis, Congenital / Q000188:drug therapy*
chemical_list: D013413:Sulfadoxine; D011739:Pyrimethamine
vernacular_title: Passage transplacentaire de l'association pyriméthamine-sulfadoxine lors du traitement anténatal de la toxoplasmose congénitale.